Comparative Gene Expression Profiling of Benign and Malignant Lesions Reveals Candidate Therapeutic Compounds for Leiomyosarcoma

Leiomyosarcoma (LMS) is a malignant, soft-tissue tumor for which few effective therapies exist. Previously, we showed that there are three molecular subtypes of LMS. Here, we analyzed genes differentially expressed in each of the three LMS subtypes as compared to benign leiomyomas and then used the...

Descripción completa

Detalles Bibliográficos
Autores principales: Edris, Badreddin, Fletcher, Jonathan A., West, Robert B., van de Rijn, Matt, Beck, Andrew H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420093/
https://www.ncbi.nlm.nih.gov/pubmed/22919280
http://dx.doi.org/10.1155/2012/805614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420093/
https://www.ncbi.nlm.nih.gov/pubmed/22919280
http://dx.doi.org/10.1155/2012/805614

Ejemplares similares